Login to get the latest articles, videos,
gallery, and a lot more…
Email
Google
Facebook
WE-Dapa M Tablet ER
Product introduction
WE-Dapa M Tablet ER may be taken with food. Take it at the same time every day, this will help you remember to take it. The dose will be decided by your doctor. Don’t stop taking it without asking your doctor.
If you do, your blood sugar levels may increase and put you at risk of serious complications like kidney damage and blindness.
This medicine is only part of a treatment program that should include a healthy diet, regular exercise, and weight reduction as advised by your doctor.
The most common side effects of this medicine include sore throat, nasal congestion, runny nose, headache, nausea, vomiting, and diarrhea. Drinking plenty of fluids while using it will help prevent dehydration.
Some people may develop fungal infections in the genital area. Maintaining good hygiene can help prevent this.
Before taking this medicine, inform your doctor if you have any kidney or liver problems or a urinary tract infection or if you are on water pills (diuretics). Pregnant or breastfeeding women should also consult their doctor before taking it.
Avoid excessive alcohol intake while taking it as this may increase the risk of developing some side effects. Monitor your blood sugar levels regularly while taking this medicine.
- Treatment of Type 2 diabetes mellitus
Usage of WE-Dapa M Tablet ER
Side effects of WE-Dapa M Tablet ER
- Nausea
- Vomiting
- Diarrhea
- Genital fungal infection
- Nasopharyngitis (inflammation of the throat and nasal passages)
- Urinary tract infection
- Polyuria
- Flatulence
- Skin rash
- Taste change
- Difficulty in urination
- Hypoglycemia (low blood glucose level)
- Tremors
- Dizziness
- Back pain
- Increased hematocrit
- Decreased creatinine clearance
- Dyslipidemia
How to use WE-Dapa M Tablet ER
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. WE-Dapa M Tablet ER is to be taken with food.
Functionality of WE-Dapa M Tablet ER
WE-Dapa M Tablet ER is a combination of two antidiabetic medicines: Dapagliflozin and Metformin. Dapagliflozin works by removing excess sugar (glucose) from your body through urine. Metformin works by lowering sugar production in the liver, delaying glucose absorption from intestines and increasing the body's sensitivity to insulin. Together, they provide better control of blood sugar.
Safety Advice
Alcohol
It is unsafe to consume alcohol with WE-Dapa M Tablet ER.
Pregnancy
WE-Dapa M Tablet ER may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Breast feeding
WE-Dapa M Tablet ER is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Driving
Your ability to drive may be affected if your blood sugar is too low or too high. Do not drive if these symptoms occur.
Kidney
WE-Dapa M Tablet ER should be used with caution in patients with kidney disease. Dose adjustment of WE-Dapa M Tablet ER may be needed. Please consult your doctor.
Liver
WE-Dapa M Tablet ER should be used with caution in patients with liver disease. Dose adjustment of WE-Dapa M Tablet ER may be needed. Please consult your doctor.
The information provided is for educational and informational purposes only. While we strive to ensure accuracy and completeness, this content should not be considered a substitute for professional medical advice, diagnosis, or treatment. Medicines, their salts, uses, and potential side effects listed are general references and may not apply to every case. Self-prescribing or altering medication based on this information without consulting a qualified healthcare professional can lead to serious health risks. Always seek the advice of a doctor or a licensed medical practitioner before starting, changing, or discontinuing any medication. Health and Me or Times Network do not assume responsibility for any consequences arising from reliance on this content. In case of any health concerns, side effects, or emergencies, please contact a medical professional immediately.
- Dapagliflozin and metformin HCl extended-release. Wilmington, Delaware AstraZeneca Pharmaceuticals LP; 2014 [revised Jul. 2017]. [Accessed 29 Apr. 2019] (online)
- Dapagliflozin + Metformin. Södertälje, Sweden AstraZeneca; 2014. [Accessed 25 Apr. 2019] (online)
- Dapagliflozin and metformin hydrochloride. [Summary of Product Characteristics]. Södertälje, Sweden AstraZeneca AB; 2021. [Accessed 13 Oct. 2021] (online)
- Dapagliflozin and metformin hydrochloride tablets [Product monograph]. Mississauga, Ontario; AstraZeneca Canada Inc.; 2020. [Accessed 13 Oct. 2021] (online)
- Medscape. Dapagliflozin+Metformin. [Accessed 25 Apr. 2019] (online)
- Central Drugs Standard Control Organization. Dapagliflozin+Metformin. [Accessed 28th Sept. 2023] (online)
- Dapagliflozin and metformin [Summary of Product Characteristics]. Södertälje, Sweden AstraZeneca AB; 2018. [Accessed 28th Sept. 2023] (online)
- European Medicine Agency. Xigduo (dapagliflozin / metformin). [Accessed 28th Sept. 2023] (online)
Name: Wellcuring Lifesciences Pvt Ltd
Address: C/O DEVI DATT INDIRA NAGER-2 BINDUKHATTA LALKUAN HALDWANI-2 NAINITAL UR 262402 UTTARAKHAND
A licensed vendor partner from your nearest location will deliver the product. Once the pharmacy accepts your order, the details of the pharmacy will be shared with you. Acceptance of your order is based on the validity of your doctor's ℞ and the availability of this medicine.
Newsletter
Stay Tuned
stay healthy